A systematic review of taxane-containing regimens for metastatic breast cancer

This publication has 21 references indexed in Scilit:

• Taxane containing regimens for metastatic breast cancer
  Published by Wiley ,2005
• Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer
  The Lancet Oncology, 2004
• Use and abuse of taxanes in the management of metastatic breast cancer
  European Journal Of Cancer, 2003
• 671 Phase III study comparing AT (Adriamycin, Docetaxel) to FAC (Fluorouracil, Adriamycin, Cyclophosphamide) as first-line chemotherapy (CT) in patients with metastatic breast cancer (MBC)
  European Journal of Cancer Supplements, 2003
• Paclitaxel and epidoxorubicin or doxorubicin versus cyclophosphamide and epidoxorubicin as first-line chemotherapy for metastatic breast carcinoma: a randomised phase II study.
  2003
• Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial
  Journal of Clinical Oncology, 2003
• Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193)
  Journal of Clinical Oncology, 2003
• Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure
  British Journal of Cancer, 2002
• Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial
  Journal of Clinical Oncology, 2002
• Beta blockade during and after myocardial infarction: An overview of the randomized trials
  Progress in Cardiovascular Diseases, 1985